Radiotherapy Market

Radiotherapy Market by Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Procedure (External (IMRT, IGRT, 3D-CRT) Internal (LDR, HDR)), Application (Prostate, Breast, Lung), End User (Hospitals) - Global Forecasts to 2026

Report Code: MD 1773 Jun, 2021, by marketsandmarkets.com

[259 Pages Report] The global radiotherapy market is valued at USD 5.9 billion in 2021 and is expected to reach USD 7.3 billion by 2026, at a CAGR of 4.2% during the forecast period. Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this market. Additionally, the growing adoption of radiotherapy procedures for cancer treatment, increasing use of particle therapy for cancer treatment, and the rising number of conferences and symposia focusing on the advancements in radiotherapy are some of the other major factors driving the growth of this market.

Radiotherapy Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the global radiotherapy market

Globally, the outbreak of COVID-19 has impacted every aspect of the medical device industry, including radiotherapy devices. From region to region, there is considerable variation in the management of radiotherapy procedures during the COVID-19 pandemic. The global cancer burden is expected to rise by 20% as a result of COVID-19. This can be attributed to the temporary postponement of various elective surgeries, as governments and authorities seek to ensure the availability of resources for COVID-19 patients. In 2020, mean weekly radiotherapy courses fell by 19.9% in April, 6.2% in May, and 11.6% in June, compared with corresponding months in 2019. A relatively greater fall was observed for attendances (29.1% in April, 31.4% in May, and 31.5% in June). Various governments have provided guidelines on elective surgeries to reduce the strain on the healthcare system, decrease disease transmission, and conserve personal protective equipment (PPE).

Though radiotherapy emergency services were available in almost all centers, the number of emergency patients visiting centers for treatment has reduced. Closed manufacturing facilities due to lockdowns have disrupted supply chains, and reduced recruitments for clinical trials further impacted the growth of the overall radiotherapy devices market in 2020.

Radiotherapy Market Dynamics

Driver: Technological advancements

Over the last decade, the radiotherapy devices market has seen significant technological advancements. These advancements have helped in the development of more effective, low-cost, and easy-to-use radiotherapy products with improved and precise radiation dose delivery to offer increased efficiency in targeting tumors. The advancement from 2D to 3D conformal radiotherapy with real-time imaging has enabled high conformity of radiation to the target (with minimal exposure to normal tissue) and dose escalation with improved tumor control. Products that provide these benefits are expected to have a very high growth potential in a short time span, especially in mature markets where the adoption rate of technologically advanced products is high.

Considering these factors, several key market players are continuously focusing on the development, approval, and launch of technologically advanced products. For example, in 2020, Elekta (Sweden) introduced its Elekta Harmony linear accelerator, a cancer treatment system with a shorter treatment slot of up to 25% and a 30% smaller footprint. In 2020, PMB, a subsidiary of the ALCEN Group, announced the launch of FLASHKNiFE, a FLASH radiotherapy system dedicated to clinical trials.

Such technological advancements focus on improving the functionality of radiotherapy delivery systems and expanding their application areas. The growing adoption of these systems in multiple applications and settings is one of the major factors driving the growth of the radiotherapy market.

Restraint: Lack of adequate healthcare infrastructure

Radiotherapy devices are larger in size and require ample space for installation. As a result, in emerging and underdeveloped economies, the lack of adequate healthcare infrastructure due to limited healthcare expenditure is one of the major factors restraining the adoption of radiotherapy systems. Currently, only a limited number of healthcare institutions in underdeveloped and developing countries are capable of using advanced radiotherapy systems for cancer treatment. This, in turn, is limiting the number of radiotherapy procedures in spite of their high demand. The WHO recommends at least one teletherapy unit per million population. As per this recommendation, the minimum required a number of teletherapy units in India is around 1,250 units as against the presently available 545 units, marking a huge shortfall of nearly 700 units.

Opportunity: Rising healthcare expenditure across developing countries

The rapid economic development and increasing healthcare expenditure in several emerging countries, such as China, India, Brazil, and Mexico, are expected to improve access to quality healthcare in these countries. This is considered a positive indicator for the radiotherapy market. The rising incidence of cancer in these countries is resulting in a growth in the demand for various radiotherapy devices and techniques. Moreover, governments across these countries are focused on providing modern and advanced healthcare services to larger proportions of their population, as well as the improvement of reimbursement coverage. Rapid growth in per-capita healthcare expenditure and the growing public demand for affordable healthcare services are driving the growth of healthcare products (including oncology devices) across these countries. This can be evidenced by the overall increase in healthcare expenditure. For example, the healthcare expenditure of India increased from 1.2% to 2.5% of the total GDP from 2019 to 2020. Whereas, in China, healthcare expenditure has increased to 12.6% to ~USD 930 billion, as the government has raised spending in the healthcare sector amidst the COVID-19 pandemic (Source: Healthcare Asia).

Challenge: Risk of radiation exposure

One of the major challenges associated with the use of radiation therapy for cancer treatment is the risk of radiation exposure. The high radiation doses involved with therapeutic exposures have the potential to cause harm to not only the patients opting for treatment but also to the healthcare staff and people in the surrounding areas in case there is involuntary radiation exposure. This may result in various side effects, such as vomiting, diarrhea, and nausea. Similarly, exposure to a large amount of radiation doses all at once may cause radiation sickness and death.

Radiotherapy Market Ecosystem

To know about the assumptions considered for the study, download the pdf brochure

The linear accelerators segment accounted for the largest share of the external beam radiotherapy market, by product, in 2020

The EBRT products segment is further categorized into linear accelerators (LINAC), particle therapy systems, and conventional cobalt-60 teletherapy units. The Linear accelerator segment accounted for the largest market share amongst the EBRT products in 2020. A linear accelerator is the primary and most widely used treatment unit in EBRT. The LINAC segment is further characterized into conventional LINAC systems and stereotactic advanced electron/cobalt-60 LINAC systems.

LINAC systems use high-energy radiofrequency electromagnetic waves to amplify the velocity of charged subatomic particles to high energies in a linear path. These accelerators consist of a few major components—a modulator, gantry, an electron gun, an RF power source, and an accelerator guide. LINACs can be used with IMRT, IGRT, 3D conformal radiotherapy (3D-CRT), and stereotactic technology. Medical LINAC systems are the most widely used devices to deliver conventional EBRT, such as IMRT, IGRT, volumetric modulated arc therapy (VMAT), SRS, and SBRT.

The breast cancer segment, by application, to register significant growth in the Internal Beam radiotherapy market over the forecast period

The internal beam radiotherapy/brachytherapy applications market is segmented into prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, and other cancers. The breast cancer segment accounted for the highest growth amongst the internal beam radiotherapy applications market in the forecast period. Brachytherapy is frequently used as a replacement for the traditional whole-breast external radiation therapy. HDR brachytherapy delivers a precise, highly concentrated radiation dose to the target tumor, with shorter treatment times and limited exposure to healthy breast tissues. Brachytherapy also helps in retaining most healthy breast tissues, thus restoring the cosmetic look of the breast. Owing to all these factors, brachytherapy has become the gold standard for the treatment of breast cancer. Early-stage breast cancer, locally advanced breast cancer with no metastasis and chest-wall breast cancer (which cannot be treated through surgery) are the major application areas for HDR brachytherapy.

Image guided radiotherapy (IGRT) segment, by procedure, accounted for the highest market share in the external beam radiotherapy market by procedures in 2020

The external beam radiotherapy segment is classified into IGRT, IMRT, stereotactic therapy, particle beam therapy, and 3D-CRT. The IGRT segment accounted for the highest share of the external beam radiotherapy market in 2020. IGRT involves the use of images taken before and during treatment, allowing radiation oncologists to adjust the position of the patient to precisely target the tumor and limit exposure to normal tissues.

Factors such as the longer treatment planning and procedural timing as well as errors due to patient positioning and lack of appropriate guidance on dose management equipment (especially in emerging countries) may pose a challenge to the growth of the IGRT market. Furthermore, image-guided radiation therapy increases the complexity associated with radiation planning and the delivery process as stringent quality assurance at every level becomes very important for effective and safe treatment.

Radiotherapy Market by Region

The Asia Pacific market is expected to grow at the highest CAGR during the forecast period

The radiotherapy market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Improving healthcare infrastructure in the region, the large patient population for target diseases, and expanding presence of key market players in the region to grab elevating opportunities offered by these countries are the key factors supporting the market growth in this region.

Key Market Players

The dominant players in the global radiotherapy market are Varian Medical Systems, Inc. (US), Elekta (Sweden) Accuray Incorporated (US), Ion Beam Applications SA (Belgium), BD (US), Eckert & Ziegler (Germany), Hitachi Ltd. (Japan), ICAD, Inc. (US), IntraOp Medical, Inc. (US), IsoRay Medical, Inc. (US), Mevion Medical Systems, Inc. (US), Panacea Medical Technologies Pvt. Ltd. (India), P-cure Ltd. (Israel), ViewRay, Inc. (US), and ZEISS Group (Germany), among others.

Varian Medical Systems (US) is one of the leading players in the global radiotherapy market. Its broad portfolio of radiotherapy systems and brachytherapy products is the key factor accounting for its large share in this market. The company is focused on organic strategies such as product launches and introduced a number of new and advanced radiotherapy systems and received regulatory approvals for products in the past three years, such as the ProBeam 360 single-room proton therapy system, ProBeam 360 with multi-room configuration, Halcyon 2.0 system, and Calypso Anchored beam transponder system for LINACS, among others. It also adopted inorganic strategies such as agreements, partnerships, collaborations, and contracts to enhance its market presence.

Scope of the report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

Product, Application, Procedure, End User, and Region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Companies covered

The dominant players in the global radiotherapy market are Varian Medical Systems, Inc. (US), Elekta (Sweden) Accuray Incorporated (US), Ion Beam Applications SA (Belgium), BD (US), Eckert & Ziegler (Germany), Hitachi Ltd. (Japan), ICAD, Inc. (US), IntraOp Medical, Inc. (US), IsoRay Medical, Inc. (US), Mevion Medical Systems, Inc. (US), Panacea Medical Technologies Pvt. Ltd. (India), P-cure Ltd. (Israel), ViewRay, Inc. (US), and ZEISS Group (Germany), among others.

This report has segmented the global radiotherapy market based on product, application, procedure, end user, and region.

Global Radiotherapy market, by Product

  • External Beam Radiotherapy
  • Electron-emitting High-energy Linear Accelerators
  • Conventional Linear Accelerators
  • Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
    • Gamma Knife
    • CyberKnife
    • TomoTherapy
  • Conventional Cobalt-60 Teletherapy Units
  • Particle Therapy Systems
    • Cyclotrons
    • Synchrotrons
    • Synchrocyclotron
  • Internal Beam Radiotherapy/Brachytherapy
    • Seeds
    • Afterloaders
    • Applicators
    • IORT Systems
  • Systemic Radiotherapy
    • Iobenguane (I-131)
    • Samarium-153
    • Rhenium-186
    • Other Systemic Radiotherapy Products*

Global Radiotherapy market, by Application

  • External Beam Radiotherapy
    • Prostate Cancer
    • Breast Cancer
    • Lung Cancer
    • Head and Neck Cancer
    • Colorectal Cancer
    • Other Cancers
  • Internal Beam Radiotherapy/Brachytherapy
    • Prostate Cancer
    • Gynecological Cancer
    • Breast Cancer
    • Cervical Cancer
    • Penile Cancer
    • Other Cancers

Global Radiotherapy market, by Procedure

  • External Beam Radiotherapy
    • Image-guided Radiotherapy
    • Intensity-modulated Radiotherapy
    • Stereotactic Therapy
    • Particle Therapy
    • 3D Conformal Radiotherapy
  • Internal Beam Radiotherapy/Brachytherapy
    • High-dose-rate Brachytherapy
    • Low-dose-rate Brachytherapy
    • Pulsed-dose-rate Brachytherapy
  • Systemic Radiotherapy
  • Intravenous Radiotherapy
  • Oral Radiotherapy
  • Instillation Radiotherapy

Global Radiotherapy market, by End User

  • Hospitals
  • Independent Radiotherapy Centers

Global Radiotherapy market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLA
  • Middle East & Africa

Recent Developments

  • In November 2020, Elekta AB (Sweden) received CE mark for the Elekta Harmony linear accelerator, clearing the technology for commercial sales in Europe.
  • In April 2020, Elekta AB (Sweden) launched Geneva, the first universal gynecological applicator for brachytherapy. Geneva applicator is CE-marked and has received US FDA 510(k) clearance. It is used for cervical cancer up to stage IIB.
  • In June 2020, Accuray Incorporated (US) launched the CyberKnife S7 System, an innovative device combining speed, advanced precision, and real-time AI-driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 33)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 STUDY SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY USED FOR THE STUDY
    1.5 MARKET STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 37)
    2.1 RESEARCH DATA
        FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                 FIGURE 2 BREAKDOWN OF PRIMARIES: RADIOTHERAPY MARKET
    2.2 MARKET ESTIMATION METHODOLOGY
        FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
           2.2.2 USAGE-BASED MARKET ESTIMATION
                 FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL RADIOTHERAPY MARKET
           2.2.3 PRIMARY RESEARCH VALIDATION
    2.3 DATA TRIANGULATION
        FIGURE 5 DATA TRIANGULATION
    2.4 RESEARCH ASSUMPTIONS
    2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 45)
  FIGURE 6 RADIOTHERAPY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
  FIGURE 7 EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
  FIGURE 8 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)
  FIGURE 9 RADIOTHERAPY MARKET SHARE, BY END USER, 2021 VS. 2026
  FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE RADIOTHERAPY MARKET

4 PREMIUM INSIGHTS (Page No. - 49)
    4.1 RADIOTHERAPY MARKET OVERVIEW
        FIGURE 11 RISING CANCER PREVALENCE ACROSS THE GLOBE TO DRIVE THE GROWTH OF THE RADIOTHERAPY MARKET
    4.2 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT AND REGION
        FIGURE 12 LINER ACCELERATORS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE
    4.3 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
        FIGURE 13 PROSTATE CANCER TREATMENT IS THE LARGEST APPLICATION OF INTERNAL BEAM RADIOTHERAPY IN NORTH AMERICA
    4.4 GEOGRAPHIC SNAPSHOT OF THE RADIOTHERAPY MARKET
        FIGURE 14 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
        FIGURE 15 RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Technological advancements
                    5.2.1.2 Expansion of the target patient population
                    5.2.1.3 Increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy
                    5.2.1.4 Growing use of particle therapy for cancer treatment
           5.2.2 KEY MARKET RESTRAINTS
                    5.2.2.1 Lack of adequate healthcare infrastructure
                    5.2.2.2 Shortage of skilled oncologists/radiologists
                    5.2.2.3 Affordability and accessibility of treatment
                    5.2.2.4 Complex nature of radiotherapy
           5.2.3 KEY MARKET OPPORTUNITIES
                    5.2.3.1 Rising healthcare expenditure across developing countries
                    5.2.3.2 Growing government and private investments to meet the increasing demand for cancer treatment
           5.2.4 CHALLENGES
                    5.2.4.1 Difficulties in visualizing tumors during radiotherapy procedures
                    5.2.4.2 Risk of radiation exposure
    5.3 PORTER’S FIVE FORCES ANALYSIS
           5.3.1 OVERVIEW
                 TABLE 1 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.3.2 THREAT OF NEW ENTRANTS
                 FIGURE 16 THREAT OF NEW ENTRANTS
           5.3.3 THREAT OF SUBSTITUTES
                 FIGURE 17 THREAT OF SUBSTITUTES
           5.3.4 BARGAINING POWER OF SUPPLIERS
                 FIGURE 18 BARGAINING POWER OF SUPPLIERS
           5.3.5 BARGAINING POWER OF BUYERS
                 FIGURE 19 BARGAINING POWER OF BUYERS
           5.3.6 DEGREE OF COMPETITION
                 FIGURE 20 DEGREE OF COMPETITION
    5.4 REGULATORY SCENARIO
           5.4.1 US
                 TABLE 2 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
           5.4.2 EUROPE
           5.4.3 JAPAN
                 TABLE 3 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
           5.4.4 EMERGING COUNTRIES
    5.5 REIMBURSEMENT SCENARIO
        TABLE 4 REIMBURSEMENT CODES FOR RADIOTHERAPY AND RELATED PROCEDURES
    5.6 ECOSYSTEM COVERAGE
    5.7 VALUE CHAIN ANALYSIS
    5.8 COVID-19 IMPACT ON THE RADIOTHERAPY MARKET
    5.9 PRICING ANALYSIS
    5.10 PATENT ANALYSIS
           5.10.1 PATENT DETAILS
                  FIGURE 21 PATENT ANALYSIS, JANUARY 2011–MARCH 2021

6 RADIOTHERAPY MARKET, BY PRODUCT (Page No. - 76)
    6.1 INTRODUCTION
        TABLE 5 RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
    6.2 EXTERNAL BEAM RADIOTHERAPY PRODUCTS
        TABLE 6 EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 7 EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.2.1 LINEAR ACCELERATORS
                 TABLE 8 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 9 LINEAR ACCELERATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.2.2 CONVENTIONAL LINEAR ACCELERATORS
                    6.2.2.1 Lower equipment and maintenance cost will drive the market for conventional LINACs
                            TABLE 10 CONVENTIONAL LINEAR ACCELERATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.2.3 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS
                 TABLE 11 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 12 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    6.2.3.1 Cyberknife
                               6.2.3.1.1 CyberKnife offers a precise radiation delivery method with specialized tracking and robotic correction capabilities
                                         TABLE 13 CYBERKNIFE MARKET, BY REGION, 2019–2026 (USD MILLION)
                    6.2.3.2 Gamma knife
                               6.2.3.2.1 Gamma Knife offers promising results for brain metastasis patients
                                         TABLE 14 GAMMA KNIFE MARKET, BY REGION, 2019–2026 (USD MILLION)
                    6.2.3.3 Tomotherapy
                               6.2.3.3.1 Continuous product development and launches adding to the growth prospects of this market segment
                                         TABLE 15 TOMOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.2.4 PARTICLE THERAPY SYSTEMS
                 TABLE 16 PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                 TABLE 17 PARTICLE THERAPY SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    6.2.4.1 Cyclotrons
                               6.2.4.1.1 Leading players in the particle therapy market mainly manufacture cyclotrons
                                         TABLE 18 CYCLOTRONS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    6.2.4.2 Synchrotrons
                               6.2.4.2.1 Increasing investments for the development of synchrotron facilities are contributing to market growth
                                         TABLE 19 SYNCHROTRONS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    6.2.4.3 Synchrocyclotrons
                               6.2.4.3.1 High space requirements of synchrocyclotrons are limiting their widespread adoption
                                         TABLE 20 SYNCHROCYCLOTRONS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.2.5 CONVENTIONAL COBALT-60 TELETHERAPY UNITS
                    6.2.5.1 High cost and risk of radiation exposure with cobalt-60 radio isotopes have hindered the growth of this segment
                            TABLE 21 CONVENTIONAL COBALT-60 TELETHERAPY UNITS MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS
        TABLE 22 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 23 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.3.1 SEEDS
                    6.3.1.1 Adverse side-effects associated with seeds limit their adoption
                            TABLE 24 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY SEEDS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.3.2 APPLICATORS
                    6.3.2.1 Manual applicators pose a high risk of radiation exposure to the patients and staff
                            TABLE 25 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.3.3 AFTERLOADERS
                    6.3.3.1 Modern afterloaders offer proper positioning and better control of isotopes inside the body of patients
                            TABLE 26 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY AFTERLOADERS MARKET, BY REGION, 2019–2026 (USD MILLION)
           6.3.4 IORT SYSTEMS
                    6.3.4.1 Growing adoption of electronic brachytherapy procedures to support the growth of this market segment
                            TABLE 27 IORT SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.4 SYSTEMIC RADIOTHERAPY
           6.4.1 IOBENGUANE (I-131)
           6.4.2 SAMARIUM-153
           6.4.3 RHENIUM-186
           6.4.4 OTHER SYSTEMIC RADIOTHERAPY PRODUCTS

7 RADIOTHERAPY MARKET, BY APPLICATION (Page No. - 97)
    7.1 INTRODUCTION
        TABLE 28 RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    7.2 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS
        TABLE 29 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 30 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.2.1 PROSTATE CANCER
                    7.2.1.1 High incidence rate and efficiency of EBRT for prostate cancer treatment to drive the growth of this market segment
                            TABLE 31 EXTERNAL BEAM RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2019–2026 (USD MILLION)
           7.2.2 BREAST CANCER
                    7.2.2.1 Therapeutic benefits of EBRT for breast cancer over other treatments to drive the growth of this market segment
                            TABLE 32 EXTERNAL BEAM RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2019–2026 (USD MILLION)
           7.2.3 LUNG CANCER
                    7.2.3.1 Radiotherapy can be used as an adjuvant therapy with surgical procedures or chemotherapy or as a curative therapy for lung cancer
                            TABLE 33 EXTERNAL BEAM RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2019–2026 (USD MILLION)
           7.2.4 HEAD & NECK CANCER
                    7.2.4.1 Benefits of EBRT will increase its use in head and neck cancer treatment
                            TABLE 34 EXTERNAL BEAM RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2019–2026 (USD MILLION)
           7.2.5 COLORECTAL CANCER
                    7.2.5.1 Availability of alternative therapeutic options to limit the growth of this market segment
                            TABLE 35 EXTERNAL BEAM RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2019–2026 (USD MILLION)
           7.2.6 OTHER CANCERS
                 TABLE 36 EXTERNAL BEAM RADIOTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2019–2026 (USD MILLION)
    7.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
        TABLE 37 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 38 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.3.1 PROSTATE CANCER
                    7.3.1.1 Precision and rapidity of brachytherapy in prostate cancer treatment to drive the growth of this market segment
                            TABLE 39 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2019–2026 (USD MILLION)
           7.3.2 GYNECOLOGICAL CANCER
                    7.3.2.1 Availability of alternatives to hinder the adoption of brachytherapy in gynecological cancer treatment
                            TABLE 40 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2019–2026 (USD MILLION)
           7.3.3 BREAST CANCER
                    7.3.3.1 Precision and rapidity of brachytherapy treatment are driving its use in breast cancer applications
                            TABLE 41 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2019–2026 (USD MILLION)
           7.3.4 CERVICAL CANCER
                    7.3.4.1 Brachytherapy is an important part of the treatment of cervical cancer patients when radiation therapy is the primary choice of curative treatment
                            TABLE 42 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR CERVICAL CANCER, BY REGION, 2019–2026 (USD MILLION)
           7.3.5 PENILE CANCER
                    7.3.5.1 Interstitial brachytherapy is the standard conservative therapy for localized penile cancer
                            TABLE 43 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PENILE CANCER, BY REGION, 2019–2026 (USD MILLION)
           7.3.6 OTHER CANCERS
                 TABLE 44 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2019–2026 (USD MILLION)

8 RADIOTHERAPY MARKET, BY PROCEDURE (Page No. - 113)
    8.1 INTRODUCTION
        TABLE 45 RADIOTHERAPY MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)
    8.2 EXTERNAL BEAM RADIOTHERAPY
        TABLE 46 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 47 EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
    8.3 IMAGE-GUIDED RADIOTHERAPY
        TABLE 48 IMAGE-GUIDED RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.3.1 INTENSITY-MODULATED RADIOTHERAPY
                    8.3.1.1 The radiation intensity of each beam in IMRT is controlled, and the beam shape changes throughout each treatment.
                            TABLE 49 INTENSITY-MODULATED RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.3.2 3D CONFORMAL RADIOTHERAPY
                    8.3.2.1 Multiple beams with 3D-CRT allow precise radiation conforming to the tumor shape and size
                            TABLE 50 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.3.3 STEREOTACTIC THERAPY
                    8.3.3.1 Stereotactic therapy offers a minimally invasive alternative to ablation surgeries
                            TABLE 51 STEREOTACTIC THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.3.4 PARTICLE THERAPY
                    8.3.4.1 Adoption of particle therapy as the primary mode of cancer treatment is increasing
                            TABLE 52 PARTICLE THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
    8.4 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
        TABLE 53 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
        TABLE 54 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.4.1 HIGH-DOSE-RATE BRACHYTHERAPY
                    8.4.1.1 Electronic brachytherapy is one of the recent advancements in this technique
                            TABLE 55 HIGH-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.4.2 LOW-DOSE-RATE BRACHYTHERAPY
                    8.4.2.1 Lower risk of radiation exposure to the surrounding tissues to support the growth of this market segment
                            TABLE 56 LOW-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
           8.4.3 PULSED-DOSE-RATE BRACHYTHERAPY
                    8.4.3.1 Pulsed-dose-rate brachytherapy combines the advantages of HDR and LDR brachytherapy
                            TABLE 57 PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
    8.5 SYSTEMIC RADIOTHERAPY
           8.5.1 INTRAVENOUS RADIOTHERAPY
           8.5.2 ORAL RADIOTHERAPY
           8.5.3 INSTILLATION RADIOTHERAPY

9 RADIOTHERAPY MARKET, BY END USER (Page No. - 126)
    9.1 INTRODUCTION
        TABLE 58 RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.2 HOSPITALS
           9.2.1 INCREASING NUMBER OF SUPPLY DEALS OF ADVANCED RADIOTHERAPY PRODUCTS BETWEEN COMPANIES AND HOSPITALS TO DRIVE MARKET GROWTH
                 TABLE 59 RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2019–2026 (USD MILLION)
    9.3 INDEPENDENT RADIOTHERAPY CENTERS
           9.3.1 RISING CONSOLIDATION OF HEALTHCARE NETWORKS IS CHALLENGING THE GROWTH OF FREE-STANDING RADIOTHERAPY CENTERS
                 TABLE 60 RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2019–2026 (USD MILLION)

10 RADIOTHERAPY MARKET, BY REGION (Page No. - 130)
     10.1 INTRODUCTION
          TABLE 61 RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
     10.2 NORTH AMERICA
          FIGURE 22 NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT
          TABLE 62 NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 63 NORTH AMERICA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
          TABLE 64 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 65 NORTH AMERICA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 66 NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 67 NORTH AMERICA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 68 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 69 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 70 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 71 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 019–2026 (USD MILLION)
          TABLE 72 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 73 NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Changes in the reimbursement scenario to drive market growth in the US
                                 TABLE 74 US: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 75 US: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 76 US: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 77 US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Increasing incidence of cancer to drive market growth in Canada
                                 TABLE 78 CANADA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 79 CANADA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 80 CANADA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 81 CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
     10.3 EUROPE
          TABLE 82 EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 83 EUROPE: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
          TABLE 84 EUROPE: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 85 EUROPE: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 86 EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 87 EUROPE: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 88 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 89 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 90 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 91 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 92 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 93 EUROPE: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Germany is the largest market for radiotherapy in Europe
                                 TABLE 94 GERMANY: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 95 GERMANY: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 96 GERMANY: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 97 GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.3.2 FRANCE
                        10.3.2.1 High healthcare expenditure in France to drive market growth
                                 TABLE 98 FRANCE: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 99 FRANCE: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 100 FRANCE: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 101 FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.3.3 UK
                        10.3.3.1 Increasing prevalence of cancer to drive market growth in the UK
                                 TABLE 102 UK: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 103 UK: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 104 UK: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 105 UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.3.4 SPAIN
                        10.3.4.1 Increasing number of conferences and government funding for cancer research to drive market growth in Spain
                                 TABLE 106 SPAIN: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 107 SPAIN: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 108 SPAIN: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 109 SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.3.5 ITALY
                        10.3.5.1 Increasing awareness activities to support market growth
                                 TABLE 110 ITALY: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 111 ITALY: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 112 ITALY: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 113 ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.3.6 REST OF EUROPE
                    TABLE 114 ROE: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 115 ROE: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 116 ROE: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 117 ROE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
     10.4 ASIA PACIFIC
          FIGURE 23 ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT
          TABLE 118 ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 119 ASIA PACIFIC: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
          TABLE 120 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 121 ASIA PACIFIC: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 122 ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 123 ASIA PACIFIC: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 124 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 125 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 126 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 127 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 128 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 129 ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Rising geriatric population and subsequent increase in the prevalence of cancer to drive market growth in Japan
                                 TABLE 130 JAPAN: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 131 JAPAN: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 132 JAPAN: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 133 JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Increasing number of strategic partnerships and supply deals to drive market growth
                                 TABLE 134 CHINA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 135 CHINA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 136 CHINA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 137 CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 High need for radiotherapy systems in the country is expected to offer growth opportunities to market players
                                 TABLE 138 INDIA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 139 INDIA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 140 INDIA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 141 INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.4.4 SOUTH KOREA
                        10.4.4.1 Increasing incidence of cancer to drive market growth in South Korea
                                 TABLE 142 SOUTH KOREA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 143 SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 144 SOUTH KOREA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 145 SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.4.5 AUSTRALIA
                        10.4.5.1 Increasing prevalence of cancer to drive market growth in Australia
                                 TABLE 146 AUSTRALIA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 147 AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 148 AUSTRALIA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 149 AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
                    TABLE 150 ROAPAC: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 151 ROAPAC: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 152 ROAPAC: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 153 ROAPAC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
     10.5 LATIN AMERICA
          TABLE 154 LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 155 LATIN AMERICA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
          TABLE 156 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 157 LATIN AMERICA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 158 LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 159 LATIN AMERICA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 160 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 161 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 162 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 163 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 164 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
          TABLE 165 LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Increasing cancer incidence to drive market growth in Brazil
                                 TABLE 166 BRAZIL: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 167 BRAZIL: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 168 BRAZIL: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 169 BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.5.2 MEXICO
                        10.5.2.1 Increasing awareness programs fueling market growth in Mexico
                                 TABLE 170 MEXICO: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                                 TABLE 171 MEXICO: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 172 MEXICO: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                 TABLE 173 MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
                    TABLE 174 ROLA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 175 ROLA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 176 ROLA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 177 ROLA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA
                    TABLE 178 MEA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 179 MEA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 180 MEA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 181 MEA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 182 MEA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 183 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 184 MEA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 185 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 186 MEA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 187 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 188 MEA: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 195)
     11.1 OVERVIEW
          FIGURE 24 KEY DEVELOPMENTS IN THE RADIOTHERAPY MARKET (JANUARY 2018 TO MAY 2021)
     11.2 MARKET SHARE ANALYSIS
             11.2.1 GLOBAL RADIOTHERAPY MARKET SHARE ANALYSIS (2020)
                    FIGURE 25 GLOBAL RADIOTHERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER (2020)
     11.3 COMPANY EVALUATION QUADRANT
             11.3.1 STARS
             11.3.2 EMERGING LEADERS
             11.3.3 PERVASIVE PLAYERS
             11.3.4 PARTICIPANTS
                    FIGURE 26 RADIOTHERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
                    FIGURE 27 RADIOTHERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS (2020)
     11.4 COMPETITIVE SCENARIO
             11.4.1 PRODUCT LAUNCHES AND APPROVALS
                    TABLE 189 RADIOTHERAPY MARKET: KEY PRODUCT LAUNCHES AND APPROVALS, JANUARY 2018 TO MAY 2021
             11.4.2 EXPANSIONS
                    TABLE 190 RADIOTHERAPY MARKET: KEY EXPANSIONS, JANUARY 2018 TO MAY 2021
             11.4.3 DEALS
                    TABLE 191 RADIOTHERAPY MARKET: KEY DEALS, JANUARY 2018 TO MAY 2021

12 COMPANY PROFILES (Page No. - 202)
     12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, MnM view)*
             12.1.1 VARIAN MEDICAL SYSTEMS, INC.
                    TABLE 192 VARIAN MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
                    FIGURE 28 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
             12.1.2 ELEKTA AB
                    TABLE 193 ELEKTA AB: BUSINESS OVERVIEW
                    FIGURE 29 ELEKTA AB: COMPANY SNAPSHOT
             12.1.3 ACCURAY INCORPORATED
                    TABLE 194 ACCURAY INCORPORATED: BUSINESS OVERVIEW
                    FIGURE 30 ACCURAY INCORPORATED: COMPANY SNAPSHOT
             12.1.4 BECTON, DICKINSON AND COMPANY
                    TABLE 195 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                    FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
             12.1.5 IBA WORLDWIDE
                    TABLE 196 IBA WORLDWIDE: BUSINESS OVERVIEW
                    FIGURE 32 IBA WORLDWIDE: COMPANY SNAPSHOT
             12.1.6 VIEWRAY, INC.
                    TABLE 197 VIEWRAY, INC.: BUSINESS OVERVIEW
                    FIGURE 33 VIEWRAY, INC.: COMPANY SNAPSHOT
             12.1.7 ISORAY MEDICAL
                    TABLE 198 ISORAY MEDICAL: BUSINESS OVERVIEW
                    FIGURE 34 ISORAY MEDICAL, INC.: COMPANY SNAPSHOT
             12.1.8 HITACHI LTD.
                    TABLE 199 HITACHI LTD.: BUSINESS OVERVIEW
                    FIGURE 35 HITACHI LTD.: COMPANY SNAPSHOT
             12.1.9 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
                    TABLE 200 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: BUSINESS OVERVIEW
             12.1.10 PROVISION HEALTHCARE
                    TABLE 201 PROVISION HEALTHCARE: BUSINESS OVERVIEW
             12.1.11 MEVION MEDICAL SYSTEMS
                    TABLE 202 MEVION MEDICAL SYSTEMS: BUSINESS OVERVIEW
             12.1.12 OPTIVUS PROTON THERAPY, INC.
                    TABLE 203 OPTIVUS PROTON THERAPY: BUSINESS OVERVIEW
             12.1.13 P-CURE
                    TABLE 204 P-CURE: BUSINESS OVERVIEW
             12.1.14 SUMITOMO HEAVY INDUSTRIES LTD.
                    TABLE 205 SUMITOMO HEAVY INDUSTRIES LTD.: BUSINESS OVERVIEW
                    FIGURE 36 SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT
                    TABLE 206 THERAGENICS CORPORATION: BUSINESS OVERVIEW
             12.1.15 ZEISS GROUP
                     TABLE 207 ZEISS GROUP: BUSINESS OVERVIEW
                     FIGURE 37 ZEISS GROUP: COMPANY SNAPSHOT
     12.2 OTHER PLAYERS
             12.2.1 INTRAOP MEDICAL, INC.
             12.2.2 ICAD, INC.
             12.2.3 ECKERT & ZIEGLER
             12.2.4 SENSUS HEALTHCARE
             12.2.5 S.I.T SORDINA IORT TECHNOLOGIES S.P.A.

*Details on Business Overview, Products Offered, Recent Developments, MnM view might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 251)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the radiotherapy market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Primary research was conducted after acquiring extensive knowledge about the global radiotherapy market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as CROs, hospitals, transplant centers, healthcare service providers, commercial service providers, academia, and research organizations) and supply-side respondents (such as presidents, CEOs, vice presidents, directors, general managers, heads of business units, and senior managers) across five major geographies, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East, and Africa. Approximately 60% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 40%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Radiotherapy Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochur

Market Estimation Methodology

A detailed market estimation approach was followed to estimate and validate the size of the global radiotherapy market and other dependent submarkets.

  • The key players in the global radiotherapy market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights on the global radiotherapy market.
  • All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources.
  •  All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Radiotherapy Market Estimation

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation:

After deriving the overall Radiotherapy market value data from the market size estimation process, the total market value data was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all the segments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various qualitative and quantitative variables as well as by analyzing regional trends for both the demand- and supply-side macro indicators.

Report Objectives:

  • To define, describe, and forecast the radiotherapy market on the basis of product, procedure, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the radiotherapy market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, Australia, South Korea, and the RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), and the Middle East & Africa
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as new product launches; agreements, partnerships, and joint ventures; mergers & acquisitions; business expansions and research & development activities in the radiotherapy market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global radiotherapy market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe radiotherapy market into Belgium, Austria, the Czech Republic, Denmark, Greece, Poland, and Russia, among other
  • Further breakdown of the Rest of Asia Pacific radiotherapy market into New Zealand, Vietnam, the Philippines, Singapore, Malaysia, Thailand, and Indonesia among other
  • Further breakdown of the Latin American radiotherapy market into Argentina, Chile, Peru, and Colombia, among other
COVID-19

Get in-depth analysis of the COVID-19 impact on the Radiotherapy Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Radiotherapy Market

Request For Special Pricing
Report Code
MD 1773
Published ON
Jun, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Radiotherapy Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home